Bard Financial Services’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$39.6K Hold
15,000
﹤0.01% 196
2025
Q1
$45.2K Hold
15,000
0.01% 200
2024
Q4
$38.4K Hold
15,000
﹤0.01% 201
2024
Q3
$55.8K Hold
15,000
0.01% 203
2024
Q2
$94.8K Hold
15,000
0.01% 208
2024
Q1
$80.6K Sell
15,000
-4,250
-22% -$22.8K 0.01% 219
2023
Q4
$96.6K Hold
19,250
0.01% 220
2023
Q3
$32.5K Hold
19,250
﹤0.01% 224
2023
Q2
$53.5K Buy
+19,250
New +$53.5K ﹤0.01% 314